EXCLUSIVE — Merck will be making a $70 billion investment in U.S.-based research and manufacturing starting in 2025, the pharmaceutical company announced on Monday.
The company will begin its planned domestic investment by starting construction on a $3 billion pharmaceutical manufacturing site in Elkton, Virginia on Monday morning. The new site will employ over 500 full-time workers and create about 8,000 construction jobs within Virginia.
As part of it’s $70 billion domestic investment over the next several years, Merck has announced four manufacturing projects across the United States in 2025, totaling $6 billion. These capital investments included a vaccine manufacturing plant in North Carolina, a biologics center in Delaware, an animal health manufacturing facility in Kansas, and Monday’s investment in Virginia.
Trending: Who is antifa’s leader?
“It’s been an extremely exciting
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!